Univest
Univest
  • Markets
  • Aarti Industries Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Aarti Industries Share: Pros and Cons Every Investor Must Know in 2026

    Aarti Industries share pros and cons: India’s largest benzene specialty chemical company at 34x PE during transition-year ROE depression analysed for 2026.

    read more
  • Clean Science and Technology Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Clean Science and Technology Share: Pros and Cons Every Investor Must Know in 2026

    Clean Science and Technology share pros and cons: green chemistry specialty leader at 35.22x PE with MEHQ and BHA global leadership analysed for 2026.

    read more
  • Sharda Cropchem Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Sharda Cropchem Share: Pros and Cons Every Investor Must Know in 2026

    Sharda Cropchem share pros and cons: India’s cheapest quality company at 11.86x PE with 21.71% ROE and agrochemical registration moat analysed for 2026.

    read more
  • Laurus Labs Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Laurus Labs Share: Pros and Cons Every Investor Must Know in 2026

    Laurus Labs share pros and cons: pharma ARV API leader transitioning to CDMO at very expensive 91x PE analysed for 2026.

    read more
  • Sumitomo Chemical India Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Sumitomo Chemical India Share: Pros and Cons Every Investor Must Know in 2026

    Sumitomo Chemical India share pros and cons: Japan MNC agrochemical subsidiary at premium 45x PE with proprietary molecule access analysed for 2026.

    read more
  • 10 Stocks to Buy Today 10 Aug 2026: Best Q1FY27 Picks

    • August 10, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    10 Stocks to Buy Today 10 Aug 2026: Best Q1FY27 Picks

    10 stocks to buy today on 10 Aug 2026: Titan, Oil India, Hitachi Energy and Nitin Spinners on strong Q1FY27 results. Full analysis and buy rationale inside.

    read more
  • Lumax Industries Q1 FY27 Results: Revenue Rs 1,223 Cr, PAT Rs 39 Cr and Key Highlights

    • August 10, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Lumax Industries Q1 FY27 Results: Revenue Rs 1,223 Cr, PAT Rs 39 Cr and Key Highlights

    Lumax Industries Q1 FY27 results: Revenue Rs 1,223 Cr (+32.60% YoY), PAT Rs 39 Cr (+76.22% YoY). Key highlights, financial analysis and FY27 outlook.

    read more
  • Emcure Pharma Share Price: USFDA Clears Sanand With VAI Status

    • August 10, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Emcure Pharma Share Price: USFDA Clears Sanand With VAI Status

    Emcure Pharma share price is in focus after the USFDA closed its Sanand, Gujarat facility inspection with VAI status, the most favourable outcome, on 10 August 2026.

    read more
  • Advanced Enzyme Q1 FY27 Results: Revenue Rs 189 Cr, PAT Rs 38 Cr and Key Highlights

    • August 10, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Advanced Enzyme Q1 FY27 Results: Revenue Rs 189 Cr, PAT Rs 38 Cr and Key Highlights

    Advanced Enzyme Q1 FY27 results: Revenue Rs 189 Cr (+2.08% YoY), PAT Rs 38 Cr (-4.58% YoY). Key highlights, financial analysis and FY27 outlook.

    read more
  • Aditya Birla Fashion Q1 FY27 Results: Revenue Rs 2,025 Cr, Net Loss Rs 242 Cr and Key Highlights

    • August 10, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Aditya Birla Fashion Q1 FY27 Results: Revenue Rs 2,025 Cr, Net Loss Rs 242 Cr and Key Highlights

    Aditya Birla Fashion Q1 FY27 results: Revenue Rs 2,025 Cr (+10.60% YoY), Net Loss Rs 242 Cr (-6.30% YoY). Key highlights, financial analysis and FY27 outlook.

    read more
  • 1
  • …
  • 815
  • 816
  • 817
  • 818
  • 819
  • …
  • 2,715